English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Nascent proteome remodeling following homeostatic scaling at hippocampal synapses

MPS-Authors

Schanzenbächer,  Christoph T.
Proteomics (Scientific Service Group), Max Planck Institute for Brain Research, Max Planck Society;

/persons/resource/persons208179

Sambandan,  Sivakumar
Synaptic Plasticity Department, Max Planck Institute for Brain Research, Max Planck Society;

Langer,  Julian D.
Proteomics (Scientific Service Group), Max Planck Institute for Brain Research, Max Planck Society;

/persons/resource/persons208206

Schuman,  Erin M.
Synaptic Plasticity Department, Max Planck Institute for Brain Research, Max Planck Society;

External Resource
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Schanzenbächer, C. T., Sambandan, S., Langer, J. D., & Schuman, E. M. (2016). Nascent proteome remodeling following homeostatic scaling at hippocampal synapses. Neuron, 92, 358-371. doi:10.1016/j.neuron.2016.09.058.


Cite as: https://hdl.handle.net/11858/00-001M-0000-002E-58CD-9
Abstract
Homeostatic scaling adjusts the strength of synaptic connections up or down in response to large changes in input. To identify the landscape of proteomic changes that contribute to opposing forms of homeostatic plasticity, we examined the plasticity-induced changes in the newly synthesized proteome. Cultured rat hippocampal neurons underwent homeostatic up-scaling or down-scaling. We used BONCAT (bio-orthogonal non-canonical amino acid tagging) to metabolically label, capture, and identify newly synthesized proteins, detecting and analyzing 5,940 newly synthesized proteins using mass spectrometry and label-free quantitation. Neither up- nor down-scaling produced changes in the number of different proteins translated. Rather, up- and down-scaling elicited opposing translational regulation of several molecular pathways, producing targeted adjustments in the proteome. We discovered ∼300 differentially regulated proteins involved in neurite outgrowth, axon guidance, filopodia assembly, excitatory synapses, and glutamate receptor complexes. We also identified differentially regulated proteins that are associated with multiple diseases, including schizophrenia, epilepsy, and Parkinson's disease.